Back to results
US 8,283,170 B2Granted
Immunoglobulin display vectors
AssigneeAbbott Biotherapeutics Corp.
InventorsRobert DuBridge, Wenge Zhang, Susan Rhodes
Life of this patent
Estimating the term…
Abstract
Disclosed are mammalian expression vectors for expressing simultaneous expression of immunoglobulins as both a secreted and cell surface bound form.
Claims15
A method for identifying recombinant cells expressing a cell surface immunoglobulin comprising:
- transfecting eukaryotic host cells with an expression vector comprising in a 5′ to 3′ direction:
- a promoter;
- a first exon encoding an immunoglobulin heavy chain variable domain;
- a second exon encoding an immunoglobulin CH1 domain;
- a third exon encoding an immunoglobulin hinge domain;
- a fourth exon encoding an immunoglobulin CH2 domain;
- a fifth exon encoding a first immunoglobulin heavy chain CH3 domain and a cell surface tether domain;
- a sixth exon encoding a second immunoglobulin heavy chain CH3 domain, wherein the polynucleotide sequence encoding said second immunoglobulin CH3 domain is identical to the polynucleotide sequence encoding said first immunoglobulin heavy chain CH3 domain;
- a CH2 splice donor site located adjacent to the 3′ end of said fourth exon encoding the immunoglobulin CH2;
- a CH3-TM splice acceptor site located adjacent to the 5′ end of said fifth exon encoding the immunoglobulin heavy chain CH3 domain and a cell surface tether domain;
- a CH3 splice acceptor site located adjacent to the 5′ end of said sixth exon encoding the second immunoglobulin heavy chain CH3 domain;
- wherein said CH2 splice donor site splices alternatively to:
- said CH3-TM splice acceptor site to form a first spliced transcript, for producing a membrane-bound immunoglobulin;
- or
- said CH3 splice acceptor site to form a second spliced transcript, for producing a secreted immunoglobulin;
- and selecting recombinant cells that specifically bind a target antigen.
13 more elements
Dependencies are inferred from the claim text.